It is surprising in view of most previously cited data, but as it was already mentioned only 17% of stage I endometrioid endometrial cancers and up to 28% of all uterine cancers including type II and advanced stages tumors express L1CAM in their cells [10, 13]. This evidence concerns the gene L1CAM and uterine cancer.